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Introduction
 CXCR3, a seven-transmembrane G-protein-coupled 
chemokine receptor, is expressed on a variety of cells, includ-
ing activated effector and memory T cells, Th1 lymphocytes, 
B cells, NK cells and endothelial cells
[1–3].  CXCR3 binds 
to multiple natural ligands, including monokine induced 
by interferon (IFN)γ (Mig or CXCL9), IFN γ-inducible 
protein 10 (IP-10 or CXCL10) and IFN-inducible T-cell α 
chemoattractant (I-TAC or CXCL11).  By binding to these 
ligands, CXCR3 plays a role in many aspects of immune 
and inflammatory responses, particularly in orchestrating 
migration and activation of circulating leukocytes
[4].  IP-10, 
which has a molecular mass of 10 kDa, is a member of the 
CXC superfamily
[4].  It is expressed in predominance in Th1-
mediated pathological inflammatory processes
[5–7].  Blockage 
of IP-10 inhibits the recruitment of effector T cells to sites of 
inflammation following injury
[8, 9].  On the other hand, IP-10 
has been shown to inhibit angiogenesis and to have antitu-
mor properties
[10, 11].  
 Sulfation of tyrosine in chemokine receptors is emerging 
as a posttranslational modification that contributes substan-
tially to ligand binding.  Tyrosine sulfation tends to occur 
in acidic regions of molecules, usually in regions containing 
multiple tyrosines
[12, 13].  Chemokine receptors, including 
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tion and activation.  Tyrosine sulfation in 7TMS is a posttranslational modification that contributes substantially to ligand 
binding.  We aimed to study the role of tyrosine sulfation of CXCR3 in the protein’s binding to IP-10.     
Methods: Plasmids encoding CXCR3 and its mutants were prepared by PCR and site-directed mutagenesis.  HEK 293T cells 
were transfected with plasmids encoding CXCR3 or its variants using calcium phosphate.  Transfected cells were labeled 
with [
35S]-cysteine and methionine or [
35S]-Na2SO3 and then analyzed by immunoprecipitation to measure sulfation.  Experi-
ments with 
125I-labeled IP-10 were carried out to evaluate the affinity of CXCR3 for its ligand.  Calcium influx assays were 
used to measure intercellular signal transduction.  
Results: Our data show that sulfate moieties are added to tyrosines 27 and 29 of CXCR3.  Mutation of these two tyrosines to 
phenylalanines substantially decreases binding of CXCR3 to IP-10 and appears to eliminate the associated signal transduc-
tion.  Tyrosine sulfation of CXCR3 is enhanced by tyrosyl protein sulfotransferases (TPSTs), and it is weakened by shRNA 
constructs.  The binding ability of CXCR3 to IP-10 is increased by TPSTs and decreased by shRNAs. 
Conclusion: This study identifies two sulfated tyrosines in the N-terminus of CXCR3 as part of the binding site for IP-10, 
and it underscores the fact that tyrosine sulfation in the N-termini of 7TMS receptors is functionally important for ligand 
interactions.  Our study suggests a molecular target for inhibiting this ligand-receptor interaction.  
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CCR5, CXCR4, CX3CR1 and CCR2b, are sulfated on their 
N-terminal tyrosines, and tyrosine sulfation is critical for 
ligand binding
[14–17].  For example, sulfated tyrosines of the 
amino terminus of CCR5 contribute to the binding of CCR5 
to MIP-1α, MIP-1β, and HIV-gp120/CD4 complexes; in 
addition, they facilitate the entry of HIV-1 into cells express-
ing CCR5 and CD4
[14].  Sulfated tyrosines also contribute 
substantially to the formation of docking sites for C5a on the 
human C5aR
[18].  Our previous work has shown that single 
sulfation of tyrosine 174 in the second extracellular loop 
(ECL2) of human C3aR forms a functional docking site for 
C3a
[19].  Thus, tyrosine sulfation may represent the functional 
state of many 7-transmembrane segment (7TMS) receptors.  
The roles of the extracellular domains of CXCR3 have 
previously been evaluated by analyzing the binding and 
function of chimeric CXCR3-CXCR1 receptors
[21].  Some 
studies have shown that the N-terminal extracellular 
domains of CXCR3 play a role in the binding of IP-10, and 
that the second extracellular loop is important for receptor 
activation
[20, 21].  Like many other chemokine receptors of 
the immune system, the N-terminus of CXCR3 contains two 
tyrosines flanked by an acidic amino acid, suggesting that 
they are candidates for sulfation
[12, 13].  
In the present study, our data show that two tyrosines, 
27 and 29, in the N-terminus of CXCR3 are sulfated, and 
that these two sulfated tyrosines synergistically play a piv-
otal role in the efficient association of CXCR3 with intact 
IP-10, as well as a role in calcium mobilization.  CXCR3 vari-
ants lacking sulfated tyrosines and ECL2 do not efficiently 
mobilize calcium in response to IP-10.  These data not only 
underscore the functional importance of sulfated tyrosine 
in the formation of docking sites for ligand binding but also 
show that the activation site is not located at the termini of 
G-protein-coupled receptors (GPCRs).
Materials and methods
Cells, plasmids, antibodies and peptides 
HEK 293T and Cf2Th cells were obtained from the 
American Tissue Type Culture Collection (CRL115544 and 
CRL1430, respectively).  Cells were grown in Dulbecco’s 
modified Eagle’s medium supplemented with 10% fetal 
bovine serum, penicillin, and streptomycin.  An expression 
plasmid encoding the human CXCR3 fused with an N-termi-
nal FLAG tag and a C-terminal hemagglutinin (HA) tag was 
generated by PCR from human lung cDNA, and subcloned 
into the pcDNA 3.1 expression vector (Invitrogen).  CXCR3 
variants with an N-terminal truncation (∆NH2), a deletion of 
ECL2 (∆ECL2), or one or more tyrosines replaced by phe-
nylalanine were prepared using the PCR-based QuikChange 
method (Stratagene) using Pfu polymerase.  The entire cod-
ing sequence of all constructs was checked by sequencing.   
The anti-FLAG antibody and the anti-HA antibody were 
purchased from BD Pharmingen (San Diego, CA).  IP-10 
(PeproTech, Rehovot, Israel) was dissolved in water at 10 
µg/µL and diluted into cell suspensions
[19].  The expression 
plasmids for human endothelin receptors A and B were con-
structed as described above.  
Using previously published methods, constructs for the 
cDNAs of human tyrosyl protein sulfotransferases (TPST) 1 
and 2 were amplified by PCR from U87 human astroglioma 
cell cDNA and subcloned into pcDNA3.1
[19, 22].  Small hair-
pin RNA (shRNA) constructs targeting nucleotides 259-276 
of TPST1 and nucleotides 73-94 of TPST2 were generated 
and subcloned into pBluescript under the control of the 
murine U6 promoter
[19, 23].  All these constructs were kindly 
provided by Dr Hyeryun CHOE, Harvard Medical School, 
Boston, MA.
Transfection, metabolic labeling and immunoprecipi-
tation of cxcr3, cxcr3 variants, endothelial receptor (etr) 
a and b 
HEK293T cells were transfected with plasmids encoding 
CXCR3 or the CXCR3 variants using calcium phosphate
[19].  
One day later, cells were washed twice with phosphate-
buffered saline (PBS), split 1:3, and labeled overnight with 
[
35S]-cysteine and methionine ([
35S]-Express, NEN) or 
[
35S]-Na2SO3 (NEN).  In some cases, cells were treated with 
5 µg/mL tunicamycin (Sigma-Aldrich) to inhibit N-glyco-
sylation 5 h prior to and during labeling
[14, 19].  For immuno-
precipitation, labeled cells were harvested and lysed in 1% 
N-dodecyl-β-D-maltoside (Anatrace) in PBS containing a 
protease inhibitor cocktail (Sigma-Aldrich and Roche Bio-
chemicals) and 0.2 mmol/L PMSF (Sigma-Aldrich).  Cell 
debris was removed by centrifugation at 18 000×g for 5 min 
at 4 
oC, and the supernatants were immunoprecipitated using 
an anti-HA antibody covalently cross-linked to protein A 
Sepharose (Amersham Pharmacia Biotech).  Immunoprecip-
itates were washed twice with 1% N-dodecyl-β-D-maltoside 
in PBS containing 0.5% SDS and once with PBS, then eluted 
with SDS sample buffer under reducing conditions by heat-
ing at 55 
oC for 10 min.  Samples were electrophoresed on 
12% SDS-Tris/glycine polyacrylamide gels and analyzed by 
autoradiography.
O- and N-linked carbohydrates were enzymatically 
removed from immunoprecipitated CXCR3 under non-de-
naturing conditions using O-glycanase (Glyko) and PNGase 
F (New England Biolabs), respectively, as recommended by www.chinaphar.com   Gao JM et al
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the manufacturers.  The reactions were then mixed with SDS 
sample buffer and analyzed as above on 12% SDS gels
[19].  
Flow cytometer analysis 
Two days after transfection, HEK 293T cells were har-
vested in 5 mmol/L EDTA/PBS and 5 mmol/L MgCl2/PBS 
and washed with PBS.  Cells (5×10
5) were incubated with 
0.5 µg/mL of the anti-FLAG antibody for 30 min, followed 
by FITC-conjugated goat anti-mouse IgG (Santa Cruz Bio-
technology) for 30 min.  Finally cells were fixed in 2% para-
formaldehyde and analyzed by fluorescence-activated cell 
sorting (FACS).  
Sodium chlorate treatment 
Transfected HEK 293T cells were cultured in medium 
containing 10 mmol/L sodium chlorate for at least 72 h
[24].  
Binding of IP-10 to cells expressing CXCR3 and 
CXCR3 variant 
Binding experiments were performed using HEK 293T 
cells transfected with wild-type CXCR3 or CXCR3 vari-
ants.  Two days after transfection, cells were detached with 
5 mmol/L EDTA in PBS, washed with DMEM, counted, 
and resuspended to a concentration of 2×10
6/mL in bind-
ing buffer [20 mmol/L HEPES (pH 7.4), 125 mmol/L 
NaCl, 1 mmol/L MgCl2, 1 mmol/L CaCl2, 5 mmol/L KCl, 
0.5 mmol/L glucose, 0.2% BSA, 0.02% sodium azide].  An 
aliquot of cells was subjected to FACS analysis to verify 
that the receptors were expressed at comparable levels.  For 
binding assays, an aliquot of 50 µL was incubated with 0.1 
nmol/L [
125I]-IP10 (NEN Life Science Products) and 0 to 
100 nmol/L of unlabeled IP-10 for 30 min at 37 ºC in a final 
volume of 100 µL.  Cells were centrifuged, washed once 
with binding buffer, and the bound C3a was determined by 
γ-counting.  
For some experiments the degree of sulfation was modi-
fied by co-transfecting the CXCR3 with plasmids encoding 
TPST1 and 2 in order to increase sulfation, or with shRNA 
constructs directed against TPST1 and 2 in order to inhibit 
sulfation.
Calcium influx mediated by the cxcr3 and cxcr3 vari-
ants 
Cf2Th cells were transfected with CXCR3 or CXCR3 
variants using the Lipofectamine method (Invitrogen).  One 
day later, the transfected Cf2Th cells were split into two parts.  
One aliquot of cells was subjected to flow cytometric analysis 
to quantify receptor expression as previously described
[19].  
The other aliquot was transferred to flasks and grown in 
DMEM for at least 24 h.  Cells were harvested, counted, and 
incubated with the indicator dye Fura-2-AM (Molecular 
Probes) for 1 h at 37 ºC in 20 mmol/L HEPES (pH 7.4), 
1 mmol/L CaCl2, 1 mmol/L MgCl2, 125 mmol/L NaCl, 5 
mmol/L KCl, 0.5 mmol/L glucose, and 0.2% BSA.  Cells 
were washed twice and resuspended in the same buffer to a 
concentration of 1×10
6/mL.  Changes in intracellular cal-
cium concentration in response to native IP-10 were deter-
mined fluorometrically at 37 
oC by monitoring the emission 
at 510 nm and the excitation at 340 and 380 nm as a function 
of a time.  Responses were quantified as the peak of the fluo-
rescence ratio of 340/380 nm.  Measurements were made 
using cells from at least three independent experiments
[19].
Statistical analysis 
To calculate relative Kd values, binding data were ana-
lyzed using Prism software (GraphPad) running an algorithm 
for nonlinear regression of homologous one-site competi-
tion binding with ligand depletion
[25].  Data are expressed 
as mean±SEM.  Comparison between multiple groups was 
performed by ANOVA.  A value of P<0.05 was considered a 
significant difference.  
Results
CXCR3 is posttranslationally modified by N-glycosy-
lation and tyrosine sulfation.
Sulfate can be incorporated into proteins at sites of N- 
or O-linked glycosylation or on tyrosines
[13].  As shown in 
Figure 1A, immunoprecipitated CXCR3 is present in pre-
dominance as a form migrating with an apparent molecular 
weight of about 45 kDa.  Because CXCR3 has two predicted 
sites of N-linked glycosylation that are also substrates for 
sulfation
[12], treating immunoprecipitated CXCR3 with 
PNGase F produces a mature form of CXCR3 of about 35 
kDa.  The predicted amino acid sequence includes a number 
of potential O-linked glycosylation sites in the N-terminal 
extracellular domain and in ECL2, and when these glycans 
are removed by treating immunoprecipitated CXCR3 with 
O-glycanase, the CXCR3 band does not shift on SDS-PAGE 
(Figure 1B).  We conclude that wt CXCR3 is modified by 
N-linked, but not O-linked, glycosylation.
Two tyrosines in the N-terminus of CXCR3 are adjacent 
to an acidic amino acid, which is a motif similar to that pre-
dicted for tyrosine sulfation.  To test whether these tyrosines 
of CXCR3 are sulfated, we added tunicamycin to the cell 
medium before and during labeling to remove N-linked 
glycosylation.  As shown in Figure 1C, cells expressing wild-
type (wt) CXCR3 labeled with [
35S]cysteine and methionine 196
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show a single major form of CXCR3 migrating at about 35 
kDa (lane 4).  As expected, only the mature band of CXCR3 
is sulfated (Figure 1C, Lane 8).  Figure 1C also shows that 
a variant of CXCR3 in which tyrosines 27 and 29 in the 
N-terminus were changed to phenylalanine did not incorpo-
rate detectable levels of [
35S]-Na2SO3, even after extended 
exposure (Lane 5).  Thus, we infer that tyrosines in the 
N-terminus of CXCR3 are sulfated and that tyrosine sulfa-
tion is independent of N-glycosylation elsewhere in CXCR3.  
Sulfated tyrosines 27 and 29 at the N-terminus of 
CXCR3 are required for the protein to bind IP-10
Posttranslational modifications are known to affect recep-
tor function, so we sought to identify the role of sulfation in 
the interactions between CXCR3 and IP-10.  Sodium chlo-
rate (NaClO3) is a selective nontoxic inhibitor of adenosine 
triphosphate (ATP) sulfurylase, which is required for for-
mation of phosphoadenosine phosphosulfate (PAPS), the 
donor for sulfation reactions
[26].  We used NaClO3 to treat 
cells expressing wt CXCR3.
As shown in Figure 2A, the binding affinity of CXCR3 for 
IP-10 was substantially lower in HEK 293T cells treated with 
10 mmol/L NaClO3 than in the same cells without NaClO3 
treatment.  The Kd values were 1.4±0.2 nmol/L for untreated 
cells and 72.3±0.2 nmol/L for NaClO3-treated cells.  
We next explored the binding site for IP-10 on CXCR3 
in greater detail.  As shown in Figure 2B, cells expressing 
wt CXCR3 showed affinity for IP-10 similar to that of cells 
expressing the ∆ECL2 variant.  In contrast, cells expressing 
∆NH2 did not show detectable binding to IP-10.  These data 
show that the N-terminus of CXCR3 is necessary for binding 
IP-10.  
To further examine the importance of tyrosines 27 and 
29 at the N-terminus for ligand binding, we studied the abil-
ity of IP-10 to associate with wt CXCR3 or with variants in 
which at least one of the two tyrosines in the N-terminus 
was mutated to phenylalanine.  Transfected HEK 293T cells 
expressed similar levels of wt CXCR3 or variants, as indi-
cated by the fluorescence intensity of anti-FLAG antibody 
staining.  These cells were tested in competition binding 
experiments with [
125I]IP-10 and increasing concentrations 
of unlabeled IP-10 as indicated.  As shown in Figure 2C, the 
cells expressing CXCR3 mutants, FDY and YDF, showed 
lower binding affinity to [
125I]IP-10 than did cells expressing 
wt CXCR3.  However, only HEK 293T cells expressing the 
FDF variant failed to bind detectably to [
125I]IP-10.  These 
data indicate that sulfated tyrosines 27 and 29 of CXCR3 are 
important for the association of CXCR3 with IP-10.
Sulfated tyrosines 27 and 29 of CXCR3 are function-
ally important for calcium mobilization induced by IP-10 
The model for ligand-receptor association has been well 
established in GPCRs, with the docking site at the N-ter-
minus and activation site in the other parts of the receptor, 
including ECL2 and transmembrane domains
[18].  As shown 
in Figure 2C, the binding site of IP-10 is at the N-terminus 
of CXCR3.  It is speculated that binding of CXCR3 to IP-10 
triggers intracellular signaling events, such as calcium mobili-
zation.
Therefore, we investigated whether the sulfated tyrosines 
in CXCR3 affect calcium influx using the calcium mobi-
lization assay.  Since for most G-protein-coupled recep-
tors,
 Cf2Th cells appear to express an intact Ca
2+ signaling 
pathway
[19], we examined the ability of Cf2Th cells trans-
Figure 1.  Tyrosines 27 and 29 in the N-terminus of the CXCR3 
are sulfated.  (A, B) HEK 293T cells were transfected with plasmids 
encoding wild-type CXCR3 with N- and C-terminal epitope tags.  
CXCR3 immunoprecipitated from [
35S]-cysteine- and methionine-
labeled cells was treated with O-glycanase or PNGase F as indicated.  
(C) HEK 293T cells were transfected with plasmids encoding wild-
type CXCR3 or the CXCR3 mutants YDF, FDY, and FDF.  After 24 h 
the transfected cells were divided up and labeled with [
35S]-cysteine 
and methionine or with [
35S]-Na2SO3.  Both sets of cells were treated 
with the N-glycosylation inhibitor tunicamycin 5 h before and during 
labeling.  Twenty-four hours after labeling, cells were harvested, lysed 
and immunoprecipitated with an antibody against the C-terminal HA 
tag.  Immunoprecipitates were analyzed under reducing conditions by 
electrophoresis on 12% SDS polyacrylamide gels.  Gels were dried and 
exposed to X-ray film.  Numbers at the left indicate the positions of 
molecular weight markers.  www.chinaphar.com   Gao JM et al
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fected with wt CXCR3 or the variants FDY, YDF, and FDF 
to mobilize calcium in response to IP-10.  IP-10 at 200 
nmol/L effectively induced effective calcium mobilization 
in cells expressing wt CXCR3, YDF, or FDY (Figure 3A and 
B), whereas no such induction was observed in cells express-
ing the FDF variant (Figure 3C).  In a parallel experiment, 
cells expressing ∆ECL2 failed to respond robustly to IP-10 
stimulation (Figure 3D).  Taken together, these data show 
that ECL2 domain contains the site of activation that allows 
CXCR3 to induce signal transduction.  
Enzymatic regulation of the sulfation of tyrosines 27 
and 29 of CXCR3
One possible explanation for a lack of IP-10 binding to 
the CXCR3 variant FDF is the absence of sulfate on tyrosines 
27 and 29.  An alternative explanation is that the expression 
of phenylalanine at this site alters receptor conformation due 
to the increase in hydrophobicity resulting from the absence 
of the hydroxyl group
[19].  We addressed these possibilities by 
altering the extent of CXCR3 sulfation.  In order to increase 
CXCR3 sulfation, HEK 293T cells were transfected with the 
plasmid encoding wt CXCR3 alone or in combination with 
the plasmids encoding TPST1 and 2.  As shown in Figure 4A, 
cells co-transfected with the plasmids encoding wt CXCR3 
and TPST 1 and 2 showed higher levels of sulfation (lane 4).  
In order to decrease CXCR3 sulfation, HEK 293T cells were 
transfected with the plasmid encoding wt CXCR3 or they 
Figure 2.  Sulfated tyrosines 27 and 29 in the N-terminus of CXCR3 
are necessary for IP-10 binding.  (A) HEK 293T cells were transfected 
with the plasmid encoding wild-type CXCR3.  One day later, cells 
were divided into two parts.  One aliquot was treated with 10 mmol/L 
NaClO3 for 72 h, while the other aliquot was grown without NaClO3 
treatment for 3 days.  (B) HEK 293T cells were transfected with 
plasmids encoding wild-type CXCR3 or the CXCR3 variants ∆NH2 
and ∆ECL2.  (C) HEK 293T cells were transfected with plasmids 
encoding wild-type CXCR3 or the CXCR3 variants YDF, FDY or 
FDF.  Transfected cells were incubated with 0.1 nmol/L [
125I]IP-10 
and the indicated concentrations of unlabeled IP-10 as described in 
Materials and Methods.  Cells were washed, and bound [
125I]IP-10 
was determined by γ-counting.  Aliquots of the same transfections 
were analyzed for receptor expression levels by flow cytometry using 
the anti-FLAG tag antibody to verify that receptors were expressed at 
comparable levels.  Data are expressed as % maximal binding. 
Figure 3.  The CXCR3 variant FDF does not mobilize calcium in 
response to IP-10.  Cf2Th cells were transfected with wild-type CXCR3 
or with the CXCR3 variants YDF, FDF, or ∆ECL2, as described in 
Materials and Methods.  Cells were loaded with the calcium indicator 
dye Fura-2 and assessed for their ability to mobilize calcium in response 
to IP-10, which was added at the time points indicated by the arrows.  
Calcium flux was displayed as the fluorescence ratio of 340 nm to 380 
nm.  Receptor expression was determined by staining with the anti-
FLAG-tag antibody.  Mean fluorescence levels were 59.3 for wild-type 
CXCR3, 48.0 for YDF, 58.9 for FDF and 56.2 for ∆ECL2; for mock-
transfected cells, the value was 7.7.  The data shown are representative 
of three independent experiments.198
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were co-transfected with wt CXCR3 and shRNA constructs.  
Cells co-transfected with the plasmids encoding wt CXCR3 
and shRNAs showed lower sulfation signal compared with 
cells transfected with wt CXCR3 (lane 5).  Furthermore, we 
assayed whether TPST and shRNA affect the ability of cells 
expressing wt CXCR3 to bind to IP-10.  As shown in Figure 
4B, while CXCR3 expression levels were quite similar, TPST 
1 and 2 increased mean maximal binding by approximately 
30%.  In contrast, the shRNA constructs decreased mean 
maximal binding by approximately 30%.  Therefore, sulfated 
tyrosines at the N-terminus of CXCR3, not conformational 
change in the protein, are required for the protein to associ-
ate with IP-10.
ETRA and ETRB are not sulfated on tyrosines 
We extended our study to examine whether tyrosine 
sulfation is a universal posttranslational modification that 
happens in other 7TMS.  Unlike chemokine receptors, recep-
tors for endothelin A and B have tyrosines adjacent to basic 
amino acids at ECL2.  As demonstrated in Figure 5, sulfate 
moiety was not detectably incorporated in either ETRA or 
ETRB, indicating that ETRA and ETRB are not sulfated 
posttranslationally (Figure 5).  
Discussion
We have shown here that tyrosines 27 and 29 in the 
N-terminus of CXCR3 are sulfated, and that these two sul-
fated tyrosines play an important role in binding IP-10.  In 
this way, the sulfated tyrosines play a role in signal transduc-
tion and calcium mobilization in response to IP-10.  This 
observation confirms the two-site model for ligand-receptor 
binding and activation of CXCR3.  
Sulfation of tyrosines is a posttranslational modification 
occurring late in the trans-Golgi network and found on a 
wide spectrum of secreted proteins, as well as on extracel-
lular regions of many membrane proteins of multicellular 
eukaryotes
[27].  It has been estimated that up to 1% of all 
tyrosines in eukaryotic proteins may be sulfated
[28].  Sulfated 
tyrosines at the N-termini of chemokine receptors play a crit-
ical role in helping these receptors bind their natural ligands.  
These include CCR5, CXCR4, CCR2b, and CX3CR1 as well 
as Duffy antigen receptor for binding chemokines
[14–17, 29].  
Previous work has indicated that sulfated tyrosines in the 
N-terminus of chemotactic C5aR help to form the docking 
site for C5a, but not the activation site
[18].  In addition, our 
work on the structure-function of human C3aR has shown 
evidence for a two-step model for C3aR function, in which 
the binding site is at tyrosine 174 in ECL2 and the activation 
site lies at some distance away from the binding site
[19].  
The molecular cloning of CXCR3 places this molecule 
in the superfamily of G-protein-coupled receptors
[30–32].  A 
splice variant of CXCR3 called CXCR3-B has recently been 
cloned.  CXCR3-B has a longer N-terminal extracellular 
domain containing 52 amino acids, and it lacks a sulfat-
Figure 5.  ETRA and ETRB are not tyrosine-sulfated.  HEK 293T cells 
were transfected with plasmids encoding endothelin receptors A and B 
carrying an HA tag at the C-terminus.  One day later, transfected cells 
were labeled in the presence of tunicamycin as described in Figure 1.
Figure 4.  Tyrosine sulfation of CXCR3 is critical for binding affinity 
to IP-10.  (A) HEK 293T cells were co-transfected with the CXCR3 
plasmid alone or with plasmids encoding TPSTs or with shRNAs 
targeting TPSTs as indicated.  Transfections were carried out in the 
presence of tunicamycin and labeled with [
35S]cysteine and methionine 
or [
35S]-Na2SO3.  Receptors were immunoprecipitated and analyzed as 
described for Figure 1.  (B) Cells from the same transfection were tested 
for maximal binding of [
125I]IP-10 after verifying by flow cytometric 
analysis that expression levels of the receptors were comparable.  Only 
transfected cultures showing similar levels of expression were used in 
the analysis.  Results are expressed as mean±SEM of four independent 
experiments. www.chinaphar.com   Gao JM et al
199
able tyrosine
[33].  In contrast, CXCR3 has a highly anionic 
tyrosine-rich N-terminal segment.  Tyrosines 27 and 29 
lie adjacent to an acidic amino acid, which is essential for 
tyrosine sulfation, and the present study shows that both of 
these tyrosines are sulfated (Figure 2C).  However, the two 
tyrosines are sulfated to the different extent.  Single tyrosine-
to-phenylalanine mutations at position 27 or 29 of CXCR3 
cause the loss of sulfation signal seen in wt CXCR3, and 
these mutations greatly reduce the protein’s binding affin-
ity for IP-10.  Only a mutant FDF, in which both tyrosines 
27 and 29 are changed to phenylalanine, fails to detectably 
incorporate sulfate.  Cells expressing FDF do not efficiently 
bind IP-10.  
Our data support the notion that tyrosine sulfation sites 
are often clustered and that sulfation of one site may depend 
on the negatively charged sulfates already present at other 
sites
[34].  For example, the tyrosines of CCR5 at positions 
3–15 are sulfated in a stepwise manner; tyrosines 14 and 15 
are sulfated first, followed by tyrosines 10 and 3
[35].  In the 
present study, to verify that the reduced binding of IP-10 
by cells expressing FDF reflects the loss of sulfate and not a 
change in receptor conformation, we attempted to increase 
or decrease the extent of sulfation by co-transfecting cells 
with the expression plasmids for CXCR3 and TPSTs, or 
with CXCR3 and shRNAs targeting TPSTs.  If sulfate were 
important for ligand binding, an increase or decrease in sul-
fation without a change in the level of receptor expression 
would lead to increased or decreased ligand binding
[19].  Our 
data suggest that TPSTs increased tyrosine sulfation and the 
affinity of the receptor for IP-10.  Conversely, when co-trans-
fections were performed with shRNA constructs targeting 
TPSTs, both sulfation and binding were inhibited, without 
a significant change in receptor expression.  The observa-
tion that CXCR3 binding was reduced only partially reflects 
enzymatic activity of TPSTs synthesized prior to transfection 
with shRNAs.
Tyrosine sulfation has been identified as a key media-
tor of protein-protein interactions involved in leukocyte 
adhesion, hemostasis and chemokine signaling
[26].  Sulfate 
is a charged and highly polarizable moiety that is likely to 
contribute free energy to binding.  Here we have shown not 
only that tyrosines 27 and 29 are sulfated but also that these 
sulfated moieties are critically important for binding native 
IP-10.  Our data that double sulfated tyrosines contribute 
to ligand binding are inconsistent with the previous report 
showing that single mutation of tyrosine 27 or 29 of CXCR3 
decreases its ability to bind its ligands, including IP-10
[36].  
There are several possible explanations for these inconsisten-
cies.  First of all, the previous authors report that the molecu-
lar weight of human CXCR3 is about 70 kDa, whereas our 
study shows that the molecular weight of human mature 
CXCR3 is about 45 kDa, consistent with the predicted 
amino acid composition.  Secondly, tyrosines 27 and 29 are 
separated by one acidic amino acid, suggesting that both of 
these two tyrosines should be sulfated
[12, 35, 37].  Thirdly, the 
previous authors were unable to exclude other factors that 
may have affected the binding of CXCR3 to IP-10, such as 
N-linked glycosylation.  More importantly, those authors did 
not determine that the decreased binding affinity was due 
to a loss of sulfate or a change in receptor conformation.  In 
contrast, we have used TPSTs and shRNAs to determine that 
sulfated tyrosines, not a conformational change in the recep-
tor, affect the binding of receptor and ligand.  Our observa-
tions in the present study clearly demonstrate that sulfated 
tyrosines 27 and 29 are functionally more important than 
other extracellular domains in binding IP-10.
Posttranslational modification occurs in chemokine 
and chemotactic receptors, including C3aR, C5aR, CCR5, 
CX3CR1, and CC2b
[15–19].  We hypothesized that tyrosine 
sulfation might be a universal phenomenon in other 7TMS 
GPCRs, such as ETRA and ETRB
[38].  However, we did not 
observe the sulfation of tyrosines in ETRA and ETRB.  Thus 
tyrosine sulfation in 7TMS GPCRs should be further exam-
ined in order to determine its functional importance for this 
case of receptor-ligand interaction.
Activation of the G-protein-coupled receptor CXCR3 by 
IP-10 has been proposed to occur by a “two-step/two-site” 
mechanism
[20, 21].  Traditionally, chemokine receptors are 
considered to possess two regions of interaction: a docking/
binding domain rich in the acidic amino acid and tyrosine-
rich N-terminus confer binding affinity; while an activation 
site, which includes the ECL2 and transmembrane helices, 
mediates the biological activity of the
 ligand
[18, 19, 39, 40].  Our 
data imply that sulfated tyrosines 27 and 29 in the N-termi-
nus of CXCR3 constitute the binding site of the receptor, 
which positions IP-10 appropriately for interaction with the 
activation site.
Many chemokine receptors have been suggested as thera-
peutic targets for inflammation
[41].  Because the pathogenesis 
of inflammation involves the interaction of many receptors 
on various cells
[4], targeting an individual receptor may not 
generate a desirable outcome.  Many chemokine receptors 
use sulfated tyrosine(s) to bind their ligands
[37].  Thus, inhi-
bition of tyrosine sulfation on these receptors may serve as a 
therapeutic target for inflammatory diseases.  200
 www.nature.com/aps Gao JM et al
Abbreviations
CXCR3, CXC receptor 3; C3aR, C3a receptor; C5aR, 
C5a receptor; CCR5, CC chemokine receptor 5; 7TMS, 
7-transmembrane segment; GPCR, G-protein-coupled 
receptor; ECL, extracellular loop; HIV, human immunodefi-
ciency virus.
Acknowledgements
This work was supported in part by grants from the 
National Natural Science Foundation of China (No 
30470767), the Beijing Natural Science Foundation (No 
7072063), and the Ministry of Education of China (No 
NCET 06-0156).  
We are grateful to Dr Hyeryun CHOE for helpful encour-
agement and plasmids, Dr Paulette L WRIGHT for critical 
reading and editing of this manuscript, Drs Wei CUI and 
Ding-hua LIU for assistance with FACS analysis and Dr Zhi-
ying ZHAO for help in performing binding experiments.  
Author contribution
Jin-ming GAO designed and performed the experiment 
and wrote the manuscript.  Ruo-lan XIANG, Lei JIANG 
and Qi-ping FENG performed the experiments.  Wen-hui 
LI designed the primers.  Zi-jiang GUO and Qi SUN carried 
out immunoprecipitation and binding experiments.  Zheng-
pei ZENG and Fu-de FANG were actively involved through-
out the entire study. 
References
1  Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis 
I, et al.  Chemokine receptor specific for IP-10 and mig: structure, 
function, and expression in activated T-lymphocytes.  J Exp Med 
1996; 184: 963–9.
2  Thomas SY, Hou R, Boyson JE, Means TK, Hess C, Olson DP, et al.  
CD1d-restricted NKT cells express a chemokine receptor profile 
indicative of Th1-type inflammatory homing cells.  J Immunol 
2003; 171: 2571–80.
3  Romagnani P, Annunziato F, Lasagni L, Lazzeri E, Beltrame C, 
Francalanci M, et al.  Cell cycle-dependent expression of CXC 
chemokine receptor 3 by endothelial cells mediates angiostatic 
activity.  J Clin Invest 2001; 107: 53–63.
4  Luster AD.  Chemokines-chemotactic cytokines that mediate 
inflammation.  N Engl J Med 1998; 338: 436–45.
5  Sørensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, 
et al.  Expression of specific chemokines and chemokine receptors 
in the central nervous system of multiple sclerosis patients.  J Clin 
Invest 1999; 103: 807–15.
6  Zhao DX, Hu Y, Miller GG, Luster AD, Mitchell RN, Libby P.  
Differential expression of the IFN-gamma-inducible CXCR3-
binding chemokines, IFN-inducible protein 10, monokine induced 
by IFN, and IFN-inducible T cells alpha chemoattractant in human 
cardiac allografts: association with cardiac allograft vasulopathy 
and acute rejection.  J Immunol 2002; 169: 1556–60.
7  Medoff BD, Wain JC, Seung E, Jackobek R, Means TK, Ginns LC, 
et al.  CXCR3 and its ligands in a murine model of obliterative 
bronchiolitis: regulation and function.  J Immunol 2006; 176: 
7087–95.
8  Hancock WW, Gao W, Csizmadia V, Faia K, Shemmeri N, Luster 
AD.  Donor-derived IP-10 initiates development of acute allograft 
rejection.  J Exp Med 2001; 193: 975–80.
9  Luster AD, Greenberg SM, Leder P.  The IP-10 chemokine binds to 
a specific cell surface heparin sulfate site shared with platelet factor 
4 and inhibits endothelial cell proliferation.  J Exp Med 1995; 182: 
219–31.
10  Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, 
Glass MC, et al.  Interferon-gamma-inducible protein 10 (IP-10) is 
an angiostatic factor that inhibits human non-small cell lung cancer 
(NSCLC) tumorigenesis and spontaneous metastases.  J Exp Med 
1996; 184: 981–92.
11  Luster AD, Leder P.  IP-10, a CXC chemokine, elicits a potent 
thymus-dependent antitumor response in vivo.  J Exp Med 1993; 
178: 1057–65.
12  Niehrs C, Huttner WB, Carvallo D, Degryse E.  Conversion of 
recombinant hirudin to the natural form by in vitro tyrosine. 
Differential substrate specifities of leech and bovine tyrosylprotein 
sulfotransferases.  J Biol Chem 1990; 265: 9314–8.
13  Rosenquist GL, Nicholas HB Jr.  Analysis of sequence require-
ments for protein tyrosine sulfation.  Protein Sci 1993; 2: 215–22.
14  Farzan M, Mirzabekov T, Kolchinsky P, Wyatt R, Cayabyab M, 
Gerard NP, et al.  Tyrosine sulfation of the amino-terminus of 
CCR5 facilitates HIV-1 entry.  Cell 1999; 96: 667–76.
15  Farzan M, Babcock GJ, Vasilieva N, Wright PL, Kiprilov E, 
Mirzabekov T, et al.  The role of post-translational modifications 
of the CXCR4 amino terminus in stromal-derived factor 1 alpha 
association and HIV-1 entry.  J Biol Chem 2002; 277: 29484–9
16  Preobrazhensky AA, Dragan S, Kawano T, Gavrilin MA, Gulina 
IV, Chakravarty L, et al.  Monocyte chemotactic protein-1 receptor 
CCR2B is a glycoprotein that has tyrosine sulfation in a conserved 
extracellular N-terminal region.  J Immunol 2000; 165: 5295–303.
17  Fong AM, Alam SM, Imai T, Haribabu B, Patel DD.  CX3CR1 
tyrosine sulfation enhances fractalkine-induced cell adhesion.  J 
Biol Chem 2002; 277: 19418–23.
18  Farzan M, Schnitzler CE, Vasilieva N, Leung D, Kuhn J, Gerard C, 
et al.  Sulfated tyrosines form the docking site of the human C5a 
anaphylatoxin receptor.  J Exp Med 2001; 193: 1059–66.
19  Gao J, Choe H, Bota D, Wright PL, Gerard C, Gerard NP.  Sulfation 
of Tyrosine 174 in the human C3aR is essential for binding of C3a 
anaphylatoxin.  J Biol Chem 2003; 278: 37902–8.
20  Xanthou G, Williams TJ, Pease JE.  Molecular characterization of 
the chemokine receptor CXCR3: evidence for the involvement 
of distinct extracellular domains in a multi-step model of ligand 
binding and receptor activation.  Eur J Immunol 2003; 33: 2927–
36.
21  Clark-Lewis I, Mattioli I, Gong JH, Loetscher P.  Structure-
function relationship between the human chemokine receptor 
CXCR3 and its ligands.  J Biol Chem 2003; 278: 289–95.    www.chinaphar.com   Gao JM et al
201
22  Choe H, Li W, Wright PL, Vasilieva N, Venturi M, Huang CC, et al.  
Tyrosine sulfation of human antibodies contributes to recognition 
of the CCR5 binding region of HIV-1 gp120.  Cell 2003; 114: 
161–70.
23  Sui G, Soohoo C, Affarel B, Gay F, Shi Y, Forrester WC.  A DNA 
vector-based RNAi technology to suppress gene expression in 
mammalian cells.  Proc Natl Acad Sci USA 2002; 99: 5515–20.
24  Xia L, Ramachandran V, McDaniel JM, Nguyen KN, Cummings 
RD, McEver R.  N-terminal residues in murine P-selectin 
glycoprotein ligand-1 required for binding to murine P-selectin.  
Blood 2003; 101: 552–9.
25  Swillens S.  Interpretation of binding curves obtained with high 
receptor concentrations: practical aid for computer analysis.  Mol 
Pharmacol 1995; 47: 1197–203.
26  Kehoe JW, Bertozzi CR.  Tyrosine sulfation: a modulator of 
extracellular protein-protein interactions.  Chem Biol 2000; 7: 
R57–61.
27  Huttner WB.   Tyrosine sulfation and the secretory pathway.  Annu 
Rev Physiol 1988; 50: 363–76.
28  Baeuerle, PA, Huttner, WB.  Tyrosine sulfation of yolk proteins 
1, 2, and 3 in Drosophila melanogaster.  J Biol Chem 1985; 260: 
6434–39.                       
29  Choe H, Moore MJ, Owens CM, Wright PL, Vasilieva N, Li W, et 
al.  Sulphated tyrosines mediate association of chemokines and 
Plasmodium vivax Duffy binding protein with the Duffy antigen/
receptor for chemokines (DARC).  Mol Microbiol 2005; 55:1413–
22
30  Gerard C, Gerard NP.  The pro-inflammatory seven transmembrane 
segment receptors of the leukocyte.  Curr Opin Immunol 1994; 6: 
140–5.
31  Lu B, Humbles A, Bota D, Gerard C, Moser B, Soler D, et al.  
Structure and function of the murine chemokine receptor CXCR3.  
Eur J Immunol 1999; 29: 3804–12.
32  Colvin RA, Campanella GS, Sun J, Luster AD.  Intracellular 
domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 
function.  J Biol Chem 2004; 279: 30219–27.
33  Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, 
Cosmi L, et al. An alternatively spliced variant of CXCR3 mediates 
the inhibition of endothelial cell growth induced by IP-10, Mig, 
and I-TAC, and acts as functional receptor for platelet factor-4. J 
Exp Med 2003; 197: 1537–49.
34   Bundgaard JR, Vuust J, Rehfeld JF. New consensus features for 
tyrosine O-sulfation determined by mutational analysis. J Biol 
Chem 1997; 272: 21700–5.
35   Seibert C, Cadene M, Sanfiz A, Chait BT, Sakmar TP. Tyrosine 
sulfation of CCR5 N-terminal peptide by tyrosylprotein 
sulfotransferases 1 and 2 follows a discrete pattern and temporal 
sequence. Proc Natl Acad Sci USA 2002; 99: 11031–6.
36   Colvin RA, Campanella GS, Manice LA, Luster AD. CXCR3 
requires tyrosine sulfation for ligand binding and a second 
extracellular loop arginine residue for ligand-induced chemotaxis. 
Mol Cell Biol 2006; 26: 5838–49.
37   Liu J, Louie S, Hsu W, Yu KM, Nicholas HB Jr, Rosenquist GL. 
Tyrosine sulfation is prevalent in human chemokine receptors 
important in lung disease. Am J Respir Cell Mol Biol 2008; 38: 
738–43.
38   Elshourbagy NA, Korman DR, Wu HL, Sylvester DR, Lee JA, 
Nuthalaganti P, et al. Molecular characterization and regulation of 
the human endothelin receptors. J Biol Chem 1993; 268: 3873–9.
39   Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, 
Arenzana-Seisdedos F, et al. Solution structure and basis for 
functional activity of stromal cell-derived factor-1; dissociation of 
CXCR4 activation from binding and inhibition of HIV-1. EMBO J 
1997; 16: 6996–7007.
40  Gether U, Kobilka BK. G protein-coupled receptors. II. Mechanism 
of agonist activation. J Biol Chem 1998; 273: 17979–82.
41  Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive 
pulmonary disease: molecular and cellular mechanisms. Eur Respir 
J 2003; 22: 672–88.